Pain

The most widespread misunderstanding is of the difference between physical dependence and addiction. Many patients, the public and sadly healthcare professionals fear that anyone taking opioid medications on a long-term basis will become addicted.

A form of non-addictive painkiller taken from the saliva of sea snails has finally been made into a pill that can be administered orally to patients with severe types of pain, according to a report published in Chemical & Engineering News.

Mayo Clinic not only wants to spur "effective application of social media tools" throughout its organization, but also to challenge the healthcare industry as a whole to sue social media tools to "improve health globally."

On July 14, 2010, the Office for Civil Rights (OCR) of the U.S. Department of Health and Human Services (HHS), issued a proposed rule containing modifications to the privacy standards, security standards, and enforcement regulations under HIPAA.

Sticking to a physical therapy exercise routine or maintaining a physically active lifestyle can help patients with osteoarthritis improve the pain, physical function, and self-perceived effect, according to the results of a study by Dutch researchers.

The FDA unveiled its proposal for long-acting painkillers during a meeting held July 22-23 before an advisory committee comprised of doctors and pain experts, but was unsuccessful in seeking approval.

Researchers from the University of California San Diego, University of Washington and Veterans' Affairs San Diego Healthcare System evaluated the influence of family history and psychological factors on the relationship between obesity and chronic pain. The team used data from large community-based samples of twins.

The ORACAL trial of Tarsa Therapeutics, Inc.'s oral calcitonin product has completed patient enrollment in a multinational, randomized, double-blind, placebo-controlled Phase III trial. The product is for the treatment of postmenopausal osteoporosis. Additionally, the trial completed two separate safety reviews of patient data by an independent data monitoring committee and is set to proceed as planned.

94 percent of physicians interviewed using smartphones to communicate, manage personal and business workflows, and access medical information

New research shows abnormal brain activity in migraineurs to be more widespread than thought.

Findings from one of the longest and largest studies on biologic knee joint repair were release by The Stone Research Foundation and published in the July issue of The British Journal of Bone & Joint Surgery.

A phase 2b double-blind, randomized, placebo-controlled clinical trial, involving topical gel candidate ARC-4558 for adults with painful diabetic neuropathy produced effective results in relieving the pain.

Experts at Methodist Center for Sports Medicine say protecting your knees while you're young may help in preventing issues from forming as you age.

The Biomerix Ventral Hernia Repair Mesh, which is the latest addition to Biomerix Corporation's soft tissue repair devices, has received FDA clearance to be marketed.

I don't consider myself a "green" fanatic, but I do recycle. So when I see someone wasting paper it drives me crazy; there go more trees.

Last Wednesday, the White House announced new regulations that will require all health insurance plans to provide certain preventive services at no cost to patients.

Two more clinical trials for Pfizer drug Tanezumab, a biological agent, studied for its effects on preventing inflammationoand pain in Osteoarthritis and other pain conditions have been halted due to concerns from the FDA.

Physicians may have a new low-cost, in-office, tool to help identify athletes at increased risk for ACL injuries, according to study results presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting.

Recent research on the powerful analgesic N60 has revealed the drug is effective in treating pain without the side effects of tolerance and addiction, according to scientists at Columbia University Medical Center.

The future of drug testing may come to include the use of nanoscopic beads that can match a drug to a disease marker and uncover viable treatments, if the results of a study published in the Journal of Molecular Recognition are taken into consideration.

Dr. Pullen examines the laws that exist in 48 states that prevent individuals from being persecuted for stopping to help at the scene of an accident.

A government study released July 15 reveals a 400% increase in substance abuse admissions for patients misusing or abusing prescription pain drugs.

This study aims to determine if coping skills training can help pain and disability in adolescents with fibromyalgia.

The researchers evaluated the practice of self-regulating in the treatment of fibromyalgia.

On June 24, 2010, the ONC published the temporary EHR certification program final rule.

Recent research on enhancing nerve generation in the peripheral nervous system may pave the way for developing new treatments.

A study shows that although physicians agree they have an obligation to report impaired or incompetent colleagues, nearly one in three would decline to do so.

Reaction to the final ruling on "meaningful use" within the healthcare community was quick and varied.

A drug being tested for osteoarthritis pain has proven effective in a model of OA pain. Manufactured by Addex Pharmaceuticals Ltd., ADX71943 modulates gamma-aminobutyric acid subtype B (GABA-B) receptors. These receptors are implicated in pain processing.

The objective of this activity is to "improve diagnostic skills related to fibromyalgia and other forms of chronic pain" and "evaluate and address comorbidities in patients with fibromyalgia."